Inside, Sales

Inside Sales and a Supremacy Dispute Put D-Wave’s Government Windfall to the Test

26.06.2026 - 13:31:35 | boerse-global.de

D-Wave faces dual pressure from a quantum supremacy dispute and insider share sales, despite record bookings, federal funding, and analyst support. Stock down 51% from peak.

D-Wave Quantum Under Siege: Insider Sales, Scientific Challenge, Stock Plunges 51%
Inside - D-Wave Quantum 26.06.2026 - Bild: ĂĽber boerse-global.de

D-Wave Quantum finds itself squeezed from two directions at once. A high-profile scientific challenge to the company’s claimed quantum supremacy is colliding with a wave of insider share sales, just as Washington funnels hundreds of millions of dollars into the sector. The stock has tumbled 51% from its October high of €38.48, recently changing hands around €19 — a level that still leaves it down roughly 10% on the week.

Scientists Push Back on Quantum Advantage

The Flatiron Institute published research suggesting that classical computers can now solve a class of problems once considered exclusive to quantum machines. D-Wave responded swiftly, arguing that the new work does not replicate the full scope of its own Science-published result and fails to tackle the hardest problem instances from that study. While the company welcomes progress in classical algorithms, it firmly rejects the notion that its quantum supremacy has been refuted.

The dispute is more than academic. D-Wave’s entire investment thesis rests on a technological lead over classical systems. Any erosion of that lead undermines the foundation of earlier rallies. The same week, a Nature article cast doubt on Microsoft’s quantum approach, dragging the entire sector lower and adding to D-Wave’s woes.

Insider Selling Piles On

Parallel to the scientific headwind, insider transactions have raised eyebrows. CFO John M. Markovich disposed of 246,043 shares on June 12 and 15, fetching prices between $24.01 and $25.75. CEO Alan Baratz exercised options on 687,627 shares and sold the entire block at an average of $26.13. A further Form-144 filing signals that another large shareholder intends to sell controlled stakes under SEC Rule 144 — a move that, while not immediate, suggests more supply could hit the market at higher levels.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

Revenue Contradiction: Weak Sales, Record Orders

The financial picture remains sharply divided. In the quarter ended March 2026, D-Wave generated just $2.86 million in revenue, a staggering 81% drop from the prior year. Operating costs of roughly $57.6 million produced a loss of nearly $54.7 million. On the balance sheet, $588 million in cash and short-term investments and a current ratio above 21 provide ample runway — but the cash burn is unmistakable.

Yet the bookings story tells a different tale. D-Wave reported quarterly bookings of $33.4 million, a roughly 2,000% surge year-over-year, driven by contracts with Fortune 100 companies and academic institutions. President Trump signed executive orders in June 2026 that unlock billions in federal quantum computing funding. The company also received roughly $100 million from the CHIPS Act in May, and the Pentagon is allocating up to $200 million annually for quantum sensors — a market where D-Wave’s annealing technology sits front and center.

Analysts Hold Firm Despite the Slide

Wall Street has not wavered. Mizuho raised its price target to $35 with a Buy rating, and Roth Capital lifted its target to $40 after the company’s Investor Day. The consensus among 15 analysts stands at $36.84 — more than double the current price. The RSI of 42.8 (or 44, depending on the calculation) suggests the stock is neither oversold nor overbought. Annualized 30-day volatility of roughly 140% underscores its extreme speculative nature.

D-Wave Quantum at a turning point? This analysis reveals what investors need to know now.

Technical Levels and the Next Catalyst

The stock has slipped below the 200-day moving average of €20.94, a bearish signal that indicates a loss of long-term momentum. That line now acts as resistance; if the shares fail to reclaim it, the next support could be the 52-week low of €11.12. The pivotal moment arrives on August 6, 2026, when D-Wave reports second-quarter results. A strong recovery in commercial orders could reignite the rally toward the analyst target of €32.45. Continued dependence on government funding, however, would validate the skeptics and risk another leg lower.

Ad

D-Wave Quantum Stock: New Analysis - 26 June

Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated D-Wave Quantum analysis...

en | US26740W1099 | INSIDE | boerse | 69632599 |